Jefferies Group’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$718K Buy
40,000
+36,500
+1,043% +$479K 0.01% 912
2022
Q2
$33.7K Sell
3,500
-39,000
-92% -$490K ﹤0.01% 1426
2022
Q1
$715K Buy
+42,500
New +$628K ﹤0.01% 958
2017
Q1
– Sell
-17,700
Closed -$85K – 2730
2016
Q4
$85K Sell
17,700
-52,000
-75% -$1.54M ﹤0.01% 2032
2016
Q3
$3.22M Buy
69,700
+38,800
+126% +$2.19M 0.02% 714
2016
Q2
$1.58M Buy
+30,900
New +$1.54M 0.01% 971

Other funds holding ISEE

Jefferies Group's ISEE Position: Q3 2022 in Review

Jefferies Group increased its IVERIC bio (ISEE) stake by 2,861% in Q3 2022, buying an estimated $247K and bringing the position to 19,510 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Jefferies Group first reported a position in ISEE in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Jefferies Group held 19,510 shares of IVERIC bio worth $350K as of Q3 2022.
  • Jefferies Group bought 18,851 IVERIC bio shares in Q3 2022, an estimated $247K.
  • IVERIC bio made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1174 holding.
  • Jefferies Group first reported a position in IVERIC bio in Q2 2015 and has held it in 8 quarters since.
  • Jefferies Group's IVERIC bio position peaked at $1.58M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.